High Quality
Open the downloaded document, and select print from the file menu (PDF reader required).
Hexavalent chromium [Cr(VI)] compounds are classied as human carcinogens [Cohen et al. 1993; International Agency or Research on Cancer (IARC) 1990; National oxicology Program (NP) 1998], based on increased incidences o lung cancers in animals and humans ater inhalation exposures. Inhalation exposures occur primarily in occupational set- tings. Te highest exposure to Cr(VI) occurs occupationally among workers involved in chrome plating, chromate production, and stainless steel welding.
As a result o industrial contamination, concentrations o Cr(VI) in the drinking water and soil may be higher than concen- trations resulting rom natural sources alone, causing ingestion o higher concentrations by populations residing near these locations than by the general population. A Cr(VI) concen- tration o 580 µg/L was ound in a ground- water monitoring well in Hinkley, Caliornia (Pellerin and Booker 2000). Detectable lev- els o Cr(VI) have been reported in approxi- mately 30% o the drinking water sources monitored in Caliornia, which has a 1 µg/L detection limit or purposes o reporting [Caliornia Department o Public Health (CDPH) 2007a]; 86% o those sources had peak concentrations o≤ 10 µg/L. Te U.S. Environmental Protection Agency (EPA) has set a maximum contaminant level o 100 µg/L or total chromium in drinking water (U.S. EPA 2003). he limit in Caliornia and
Te toxicity o Cr(VI) in humans and ani- mals has been reviewed extensively (Agency or oxic Substances and Disease Registry 2000; Costa 1997; Costa and Klein 2006; U.S. EPA 1998). We identied only one lietime animal carcinogenicity study in the literature in which Cr(VI) was administered in the drinking water (Borne et al. 1968). Further analysis o the data (Sedman et al. 2006) revealed that in three generations o emale NMRI mice, the combined incidences o benign and malig- nant orestomach neoplasms were increased over controls; this study has several limita- tions, including high early mortality in the F0 generation as a result o ectromelia (mouse- pox) virus. A review o the ew epidemiologic studies that evaluated populations that were exposed to Cr(VI) in drinking water or in soil or slag ll concluded that these studies did not provide denitive evidence o an increase in cancer incidence or mortality rates (Proctor et al. 2002). However, a retrospective mortal- ity study in China ound higher incidences o lung and stomach neoplasms in people living near a chromium smelting plant compared with the general population (Zhang and Li 1987); statistical analysis o these data sup- ported this conclusion (Beaumont et al. 2008; Sedman et al. 2006).
health eects, including carcinogenicity, and the lack o adequate carcinogenicity studies by the oral route, the Caliornia Congressional Delegation, Caliornia Environmental Protection Agency, and Caliornia Department o Health Services nominated Cr(VI) to the NP or toxicity and carcinogenicity testing. We selected sodium dichromate dihydrate (SDD) or testing because it is the primary base material or the production o chromium com- pounds, is widely used in industrial applica- tions, and is the most water-soluble chromate.
Te NP previously conducted 3-month toxicity studies o SDD administered in drinking water (NP 2007). F344/N rats and B6C3F1 mice were exposed to 0, 62.5, 125, 250, 500, or 1,000 mg SDD/L. In these studies, both rats and mice had reduced body weight and water consumption and microcytic hypochromic anemia; the anemia was more severe in rats. Exposure-related histopathologic lesions included ulcers, epithelial hyper plasia, and squamous metaplasia in the glandular stomach o rats; epithelial hyperplasia o the duodenum o mice; and histiocytic cellular inltration in the liver, duodenum, and pan- creatic lymph node o rats and in the duode- num and mesenteric lymph node o mice.
We selected exposure concentrations or the 2-year studies o SDD ater review o the 3-month toxicity study data. Te highest exposure concentration or the 2-year stud- ies in rats and mice was limited by toxicity observed in the 3-month studies (NP 2007), and a wider spacing o exposure concentra- tions was selected to extend the dose–response curve. We added an additional low-exposure group [5 mg Cr(VI)/L] to the 2-year studies to provide a concentration closer to human exposure through contaminated drinking water. In this report we present the primary ndings o the NP chronic oral toxicity and
Address correspondence to M.J. Hooth, NIEHS, P.O. Box 12233, MD K2-13, Research riangle Park, NC 27709 USA. elephone: (919) 316-4643. Fax: (919) 541-4255. E-mail: hooth@niehs.nih.gov
Tis research was supported in part by the Intramural Research Program o the National Institutes o Health, National Institute o Environmental Health Sciences, under research project 1 Z01 ES045004-11 BB.
thelium that lines the oral cavity (oral mucosa and tongue) in male and emale rats, and o the epi- thelium lining the small intestine in male and emale mice. Cr(VI) exposure did not aect survival but resulted in reduced mean body weights and water consumption, due at least in part to poor pal- atability o the dosed water. Cr(VI) exposure resulted in transient microcytic hypochromic anemia in rats and microcytosis in mice. Nonneoplastic lesions included diuse epithelial hyperplasia in the duodenum and jejunum o mice and histiocytic cell infltration in the duodenum, liver, and mesen- teric and pancreatic lymph nodes o rats and mice.
carcinogenesis studies o Cr(VI) in male and emale rats and mice; a more detailed report on these studies is available as an NP techni- cal report (NP 2008a).
7789-12-0) was obtained rom Aldrich Chemical Company (Milwaukee, WI). he purity was determined using dierential scan- ning calorimetry, titration o the dichromate ion with sodium thiosulate and potassium errocyanide, speciation o the chromium ions using liquid chromatography/inductively cou- pled plasma-mass spectrometry, and poten- tiometric titrimetric analysis with sodium thiosulate. Based on these analyses, the overall purity was ≥ 99.7%. he dose ormulations were prepared approximately every 2 weeks by mixing SDD with tap water and stored at room temperature in sealed containers pro- tected rom light. Te dose ormulations were stable or 42 days under these conditions. Periodic analysis by ultraviolet spectroscopy with detection at 350–390 nm conrmed that all dose ormulations varied by < 10% o the target concentrations.
studies were conducted at Southern Research Institute (Birmingham, AL). Male and emale F344/N rats and B6C3F1 mice were obtained rom aconic Farms (Germantown, NY). Rats and mice were quarantined or 14 days, and were 6–7 weeks o age at the beginning o the studies. Animals were distributed randomly into groups o approximately equal initial mean body weights and identied by tail tattoo. Rats and mice were housed one (male mice), three (male rats), or ve (emale rats and mice) to a cage. Feed (irradiated NP-2000 waers; Zeigler Brothers, Inc., Gardners, PA) and tap water were available ad libitum. Animals were killed by carbon dioxide asphyxiation.
Animal use was in accordance with the U.S. Public Health Service policy on humane care and use o laboratory animals and the
Animals were treated humanely and with regard or alleviation o suering. hese studies were conducted in compliance with the Food and Drug Administration Good Laboratory Practice Regulations (Food and Drug Administration 1987).
50 emale rats and mice were exposed to SDD in drinking water at concentrations o 0, 14.3, 57.3, 172, or 516 mg/L (male and emale rats and emale mice) or 0, 14.3, 28.6, 85.7, or 257.4 mg/L (male mice) or 105–106 weeks. able 1 shows corresponding Cr(VI) concen- trations. Water consumption was recorded weekly or the rst 13 weeks and every 4 weeks thereater, with each water consumption
measurement covering a 7-day period. Animals were weighed initially, weekly or the rst 13 weeks, at 4-week intervals thereater, and at the end o the studies. Animals were observed twice daily and clinical ndings were recorded at 4-week intervals beginning at week 5.
Complete necropsies and microscopic examinations were perormed on all core study rats and mice. At necropsy, all organs and tis- sues were examined or grossly visible lesions, and all protocol-required tissues were xed and preserved in 10% neutral buered ormalin (eyes were initially ixed in Davidson’s solu- tion), trimmed and processed, embedded in paran, sectioned to a thickness o 4–6 µm, and stained with hematoxylin and eosin (H&E) or microscopic examination. For all paired organs (e.g., adrenal gland, kidney, ovary), samples rom each organ were examined. Te entire gastrointestinal tract was opened and potential lesions were collected or microscopic evaluation. Oral mucosa and tongue are not protocol-required tissues; however, because gross lesions in these tissues were diagnosed as neoplasms, the oral mucosa and tongue o all animals were evaluated histologically. Additional details regarding the pathology data generation, quality assurance review, and NP pathology working group are available in the NP technical report (NP 2008a). Details o these review procedures have been described, in part, by Maronpot and Boorman (1982) and Boorman et al. (1985). For subsequent analyses o the pathology data, the decision o whether to evaluate the diagnosed lesions or each tissue type separately or combined was based on the guidelines o McConnell et al. (1986).
rats and emale mice on days 4 (male rats only) and 22 and at 3, 6, and 12 months. At these time points, rats and mice were anes- thetized with CO2/O2, and blood was taken rom the retroorbital sinus.
probability o survival by the product-limit pro- cedure o Kaplan and Meier (1958). Animals ound dead o other than natural causes or missing were censored rom the survival analy- ses; animals dying rom natural causes were not censored. Statistical analyses or possible dose- related eects on survival used Cox’s (1972) method or testing two groups or equality and arone’s (1975) lie table test to identiy dose- related trends. All reportedp-values or the survival analyses are two sided.
We used the poly-k test (Bailer and Portier 1988; Piegorsch and Bailer 1997; Portier and Bailer 1989) to assess neoplasm and non- neoplastic lesion incidence. Tis test is a sur- vival-adjusted quantal-response procedure that modiies the Cochran-Armitage linear trend test to take survival dierences into account; we used a value ok = 3 in the analysis o site- specic lesions. ests o signicance included pairwise comparisons o each exposed group with controls and a test or an overall exposure- related trend. We used continuity-corrected poly-3 tests in the analysis o lesion incidence, and reportedp-values are one sided. Sub- and supralinear trends across doses or intestinal tumor rates were assessed with lack-o-t tests or the linear regression o intestinal tumor rate on dose (Neter et al. 1996).
We analyzed hematology and clinical chemistry data, which typically have skewed distributions, using the modiied (Dunn 1964; Williams 1986) nonparametric multiple
comparison methods o Shirley (1977). We used Jonckheere’s test (Jonckheere 1954) to assess the signicance o the dose-related trends and to determine whether a trend-sensitive test (Shirley 1977; Williams 1986) was more appropriate or pairwise comparisons than a test that does not assume a monotonic dose- related trend (Dunn 1964; Dunnett 1955). Beore statistical analysis, we examined extreme values identied by the outlier test o Dixon and Massey (1957) and eliminated implausible values rom the analysis.
emale rats showed signiicantly increased incidences o highly aggressive neoplasms o the squamous epithelium that lines the oral cavity (oral mucosa and tongue) at 516 mg/L (able 2). Specically, we observed increases or squamous cell carcinoma in the oral mucosa and or squamous cell papilloma or carcinoma (combined) o the oral mucosa or tongue o male and emale rats at 516 mg/L. here were squamous cell carcinomas in the oral mucosa o two 172 mg/L emale rats; this incidence exceeded the historical control ranges or drinking water studies and or all routes o administration (able 2). We did not observe non-neoplastic lesions in the oral mucosa.
Microscopically, the squamous cell carci- nomas were highly invasive, irregular masses. ypically, the carcinomas appeared to origi- nate in the oral mucosa o the palate adja- cent to the upper molar teeth (Figure 1A, B); in some animals they invaded the tongue, Harderian gland, and the sot tissues sur- rounding the nose, and in one case it pene- trated the maxilla and invaded the brain. Te squamous cell papillomas o the oral mucosa and tongue were exophytic masses that
projected rom the mucosa and consisted o irregular papillary prolierations o mature squamous epithelium supported by a core o brovascular stroma (Figure 1C).
a clear exposure concentration response or increased incidences o adenoma or carcinoma (combined) at all sites (combined) o the small intestine (duodenum, jejunum, or ileum; able 3). Tese increases were signicant at 85.7 and 257.4 mg/L in males and at 172 and 516 mg/L emales, the two highest exposure concentrations in each sex. In addition, the incidence in 57.3 mg/L emales exceeded the historical control ranges or drinking water studies and or all routes o administration (able 3). Tese increases were driven primar- ily by signicant increases in the incidences o adenoma o the duodenum in 257.4 mg/L males and in 172 and 516 mg/L emales; the number o mice with multiple adenomas was also signicantly increased at the high dose in both sexes (data not shown). In emales, the incidence o carcinoma in the duodenum was signiicantly increased at 516 mg/L. In the jejunum, the incidence o adenoma was increased in 516 mg/L emales. For both males and emales, we tested the combined incidence o adenoma and carcinoma or departures rom a linear dose response (data not shown). For males, the trend was linear, with no signicant departure rom linearity. For emales, the response was supralinear with a signicant departure rom linearity.
Adenomas were discrete, broad based, ocally extensive, plaquelike areas o proli- erating glandular epithelium that thickened the mucosa and protruded into the lumen (Figure 1D). Carcinomas were sessile, plaque- like neoplasms distinguished rom adenomas
by extensive invasion and eacement o the mucosa, underlying submucosa, and muscle layers (Figure 1E).
Low incidences o ocal epithelial hyper- plasia occurred in the duodenum o exposed male and emale mice (able 4). Although the increased incidences were not exposure concentration related or statistically signii- cant, we considered this lesion a preneoplastic lesion related to exposure to SDD because o its morphologic similarities to adenoma. Focal epithelial hyperplasias were ocal areas o pro- lierating glandular epithelium distinguished rom adenomas because they were smaller, less discrete, and conned to the supercial mucosal epithelium (Figure 1F).
Te incidences o diuse epithelial hyper- plasia were signicantly increased in the duo- denum o all exposed groups o male and emale mice (able 4). In the jejunum, the incidence o diuse epithelial hyper plasia was signicantly increased in 516 mg/L emales. In contrast to those o the controls (Figure 1G), the duodenums o exposed mice had short, broad, blunt villi and generalized mucosal hypercellularity that was particularly promi- nent in the villi (Figure 1H).
We ound signicant increases in histiocytic cell inltration in the duodenum and mesen- teric lymph node o rats and mice o both sexes, in the jejunum o emale mice, in the liver o male and emale rats and emale mice, and in the pancreatic lymph node o emale rats and male and emale mice; these data are presented in detail in the NP technical report (NP 2008a).
Te inltrating histiocytes were morpho- logically similar in tissues o rats and mice. Histiocytic iniltrates were characterized by the presence o individual, small clusters, and
7/49 (15.7)**
Females
Oral mucosa
torical control range or both drinking water studies and all routes but was not signifcantly increased compared with the concurrent control.eThe incidence exceeded the historical control range or drinking water studies but was not signifcantly increased compared with the concurrent control. *p ≤ 0.05, **p ≤ 0.01, and#p ≤ 0.001 compared with the control group by poly-3 test or a signifcant trend i assigned to a control group.
Add a Comment